Lanzhou Institute of Biological Products · 66-41 · CHINA
For Lanzhou Institute of Biological Products, import alert is 66-41; country is CHINA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Botulinum Toxin Type A & B | Botulinum Toxin Type A & B | Botulinum Toxin Type A & B; product code is 53 - - - -- Cosmetics | 65 Q - - 02 Botox | 65 Q - - 07 Myobloc; date published is 04/23/2020; address is 178 Yanchanglu , Lanzhoushi, Gansusheng CHINA, verified against its source on 2026-10-01.
- Firm
- Lanzhou Institute of Biological Products verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- CHINA verified
- Address
- 178 Yanchanglu , Lanzhoushi, Gansusheng CHINA verified
- Date published
- 04/23/2020 verified
- Product code
- 53 - - - -- Cosmetics | 65 Q - - 02 Botox | 65 Q - - 07 Myobloc each item verified
- Product
- Botulinum Toxin Type A & B | Botulinum Toxin Type A & B | Botulinum Toxin Type A & B each item verified
What the source says
Lanzhou Institute of Biological Products Date Published : 04/23/2020 178 Yanchanglu , Lanzhoushi, Gansusheng CHINA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code and Product
53 - - - -- Cosmetics Date Published: 04/23/2020 Desc: Botulinum Toxin Type A & B 65 Q - - 02 Botox Date Published: 04/23/2020 Desc: Botulinum Toxin Type A & B 65 Q - - 07 Myobloc Date Published: 04/23/2020 Desc: Botulinum Toxin Type A & B
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.